Fresenius SE Income from Continuous Operations 2016-2025 | FSNUY

Fresenius SE income from continuous operations from 2016 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
Fresenius SE Annual Income from Continuous Operations
(Millions of US $)
2024 $938
2023 $258
2022 $2,230
2021 $3,335
2020 $3,225
2019 $3,392
2018 $4,386
2017 $3,428
2016 $2,981
2015 $2,551
Fresenius SE Quarterly Income from Continuous Operations
(Millions of US $)
2025-03-31 $496
2024-12-31 $287
2024-09-30 $351
2024-06-30 $-13
2024-03-31 $314
2023-12-31 $-589
2023-09-30 $169
2023-06-30 $181
2023-03-31 $497
2022-12-31 $403
2022-09-30 $555
2022-06-30 $600
2022-03-31 $672
2021-12-31 $870
2021-09-30 $803
2021-06-30 $853
2021-03-31 $809
2020-12-31 $739
2020-09-30 $874
2020-06-30 $806
2020-03-31 $805
2019-12-31 $926
2019-09-30 $840
2019-06-30 $816
2019-03-31 $811
2018-12-31 $1,027
2018-09-30 $813
2018-06-30 $1,689
2018-03-31 $858
2017-12-31 $1,030
2017-09-30 $809
2017-06-30 $790
2017-03-31 $800
2016-12-31 $851
2016-09-30 $758
2016-06-30 $734
2016-03-31 $638
2015-12-31 $393
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.000B $23.628B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.463B 19.18
Encompass Health (EHC) United States $12.251B 25.97
DaVita (DVA) United States $10.411B 14.64
Chemed (CHE) United States $8.228B 25.86
Elanco Animal Health (ELAN) United States $6.903B 14.79
Option Care Health (OPCH) United States $5.224B 23.28
RadNet (RDNT) United States $4.401B 279.29
Amedisys (AMED) United States $3.081B 20.73
LifeStance Health (LFST) United States $2.271B 0.00
Addus HomeCare (ADUS) United States $2.082B 22.85
Astrana Health (ASTH) United States $1.416B 35.08
U.S Physical Therapy (USPH) United States $1.174B 30.29
Aveanna Healthcare Holdings (AVAH) United States $1.075B 61.22
Pennant (PNTG) United States $1.019B 37.40
Atai Life Sciences (ATAI) Germany $0.483B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.045B 0.00
Daxor (DXR) United States $0.045B 0.00
Ontrak (OTRK) United States $0.006B 0.00
Psychemedics (PMD) United States $0.000B 0.00